Approvals (Drugs@FDA)

Xeomin

MERZ PHARMS · incobotulinumtoxinA

BLA125360Biologic (BLA)Prescription
Open FDA's page for this record
Application number
BLA125360
Sponsor name
MERZ PHARMS
Submissions
  1. Submission type
    SUPPL
    Submission number
    66
    Submission status
    AP
    Submission status date
    20151120
    Submission class code
    MANUF (CMC)
    Submission class code description
    Manufacturing (CMC)
    Application docs
    1. ID
      18887
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125360s066lbl.pdf
      Date
      20151125
      Type
      Label
  2. Submission type
    SUPPL
    Submission number
    99
    Submission status
    AP
    Submission status date
    20240705
    Review priority
    STANDARD
    Submission class code
    EFFICACY
    Submission class code description
    Efficacy
  3. Submission type
    SUPPL
    Submission number
    107
    Submission status
    AP
    Submission status date
    20260320
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
    Application docs
    1. ID
      85523
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125360Orig1s107lbl.pdf
      Date
      20260325
      Type
      Label
    2. ID
      85524
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/125360Orig1s107ltr.pdf
      Date
      20260325
      Type
      Letter
  4. Submission type
    SUPPL
    Submission number
    97
    Submission status
    AP
    Submission status date
    20230908
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
    Application docs
    1. ID
      75386
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/125360Orig1s097ltr.pdf
      Date
      20230911
      Type
      Letter
    2. ID
      75447
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125360s097lbl.pdf
      Date
      20230913
      Type
      Label
  5. Submission type
    SUPPL
    Submission number
    89
    Submission status
    AP
    Submission status date
    20210419
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
    Application docs
    1. ID
      67121
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
      Date
      20210420
      Type
      Label
    2. ID
      67128
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
      Date
      20210422
      Type
      Letter
  6. Submission type
    SUPPL
    Submission number
    87
    Submission status
    AP
    Submission status date
    20210419
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
    Application docs
    1. ID
      67119
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
      Date
      20210420
      Type
      Label
    2. ID
      67126
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
      Date
      20210422
      Type
      Letter
  7. Submission type
    SUPPL
    Submission number
    40
    Submission status
    AP
    Submission status date
    20120716
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
    Application docs
    1. ID
      9721
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/125360Orig1s040ltr.pdf
      Date
      20120718
      Type
      Letter
  8. Submission type
    SUPPL
    Submission number
    93
    Submission status
    AP
    Submission status date
    20210813
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
    Application docs
    1. ID
      68374
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s093ltr.pdf
      Date
      20210816
      Type
      Letter
    2. ID
      68393
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s093lbl.pdf
      Date
      20210817
      Type
      Label
  9. Submission type
    SUPPL
    Submission number
    91
    Submission status
    AP
    Submission status date
    20210419
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
    Application docs
    1. ID
      67123
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s087s088s089s090s091lbl.pdf
      Date
      20210420
      Type
      Label
    2. ID
      67130
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125360Orig1s087, s088, s089, s090, s091ltr.pdf
      Date
      20210422
      Type
      Letter
  10. Submission type
    SUPPL
    Submission number
    7
    Submission status
    AP
    Submission status date
    20110720
    Review priority
    STANDARD
    Submission class code
    EFFICACY
    Submission class code description
    Efficacy
    Application docs
    1. ID
      18885
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125360s007lbl.pdf
      Date
      20110725
      Type
      Label
  11. Submission type
    SUPPL
    Submission number
    67
    Submission status
    AP
    Submission status date
    20151222
    Review priority
    STANDARD
    Submission class code
    EFFICACY
    Submission class code description
    Efficacy
    Application docs
    1. ID
      39938
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125360s067lbl.pdf
      Date
      20151228
      Type
      Label
    2. ID
      31941
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/125360Orig1s067ltr.pdf
      Date
      20151229
      Type
      Letter
  12. Submission type
    SUPPL
    Submission number
    73
    Submission status
    AP
    Submission status date
    20180703
    Review priority
    PRIORITY
    Submission class code
    EFFICACY
    Submission class code description
    Efficacy
    Application docs
    1. ID
      54742
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125360s073lbl.pdf
      Date
      20180703
      Type
      Label
    2. ID
      54782
      Url
      http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/125360Orig1s073ltr.pdf
      Date
      20180706
      Type
      Letter
  13. +13 more not shown
Products
  1. Product number
    003
    Reference drug
    No
    Brand name
    Xeomin
    Reference standard
    No
    Dosage form
    INJECTABLE
    Route
    INJECTION
    Marketing status
    Prescription
    Active ingredients
    1. Name
      incobotulinumtoxinA
      Strength
      200 UNITS/VIAL
  2. Product number
    001
    Reference drug
    No
    Brand name
    Xeomin
    Dosage form
    INJECTABLE
    Route
    INJECTION
    Marketing status
    Prescription
    Active ingredients
    1. Name
      incobotulinumtoxinA
      Strength
      50 UNITS/VIAL
  3. Product number
    002
    Reference drug
    No
    Brand name
    Xeomin
    Dosage form
    INJECTABLE
    Route
    INJECTION
    Marketing status
    Prescription
    Active ingredients
    1. Name
      incobotulinumtoxinA
      Strength
      100 UNITS/VIAL
Harmonized identifiers (openFDA)
Application number
BLA125360
Brand name
XEOMIN
Generic name
INCOBOTULINUMTOXINA
Manufacturer name
Merz Pharmaceuticals, LLC, Merz North America, Inc.
Product NDC
0259-1605, 0259-1610, 0259-4150, 0259-4110, 0259-1620, 46783-160, 46783-161, 46783-165
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAMUSCULAR
Substance name
BOTULINUM TOXIN TYPE A
RxCUI
1000107, 1009456, 1009459, 1732157, 1732161, 1732165
SPL ID
75c52aa4-0780-4e18-bac3-ba1440a74dee, 8b2d961a-6bb4-4bef-ac07-7dcc2bbfacc7
SPL set ID
ccdc3aae-6e2d-4cd0-a51c-8375bfee9458, 3f35d6e0-3450-4abc-a0da-cc7b277e7c6e
Package NDC
0259-1605-01, 0259-1610-01, 0259-4150-01, 0259-4110-01, 0259-1620-01, 0259-1620-10, 46783-161-01, 46783-160-01, 46783-160-10, 46783-165-01
Nui
N0000175771, N0000193962, N0000175731, N0000175770
Pharm class epc
Acetylcholine Release Inhibitor [EPC], Neuromuscular Blocker [EPC]
Pharm class pe
Neuromuscular Blockade [PE]
Pharm class moa
Acetylcholine Release Inhibitors [MoA]
UNII
E211KPY694
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.